Sardocor Corp.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Sardocor Corp.
RECRUITINGPhase 1NCT06061549
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction
The goal of this clinical trial is to test an experimental gene therapy in participants with heart failure with preserved ejection fraction, also known as diastolic heart failure....
Sponsor: Sardocor Corp.Enrolling: 102 locations
Heart Failure, DiastolicHeart Failure With Preserved Ejection Fraction
RECRUITINGPhase 1NCT06224660
Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
This research study is testing whether an experimental drug, called SRD-001, is safe and helps the weakened heart of patients with Duchenne muscular dystrophy (DMD) regain its...
Sponsor: Sardocor Corp.Enrolling: 123 locations
DMD-Associated Dilated Cardiomyopathy